- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01647490
Right Ventricular Lead Placement in a Pacemaker Population: Evaluation of Apical and Alternative Position
Right Ventricular Lead Placement in a Pacemaker Population: Evaluation of Apical and Alternative Position - Right Pace Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Permanent cardiac pacing plays an important role in cardiac disease management. Since early studies on right ventricular pacing, apex has been the preferred implant site for transvenous endocardial ventricular leads for several reasons: ease of placement, lead stability as well as the design characteristics of the electrode and the fixation system.
It is now also accepted, however, that right ventricle pacing causes a long term deterioration of left ventricular function through complex effects, both at the structural level of the heart wall and at the hemodynamic level in left ventricular load conditions. It is possible that this deterioration is due to a dyssynchrony of contraction induced by pacing at the right ventricular apex. Some authors suggest to pace the right ventricle at alternative sites, i.e. the medium septum (RVS) region, to guarantee a more physiological activation pattern, especially in patients expected to receive high pacing percentages.
However, unequivocal evidences that stimulation of the right ventricular septum is more physiological than the apical pacing are still missing.
Nonetheless, it should be noted that, although a number of studies refer to RV septum as the alternative site for pacing , poor attention has been paid to the unambiguous definition of RV septum region itself. A clear definition and a proper evaluation of the alternative site is therefore important.
Furthermore, from a procedural point of view, it has been demonstrated that acute and chronic electrical performances of the leads positioned at alternative sites, in particular in the region of mid septum, are equivalent to those of the leads positioned at the apical site.
The purpose of this study is to perform a comprehensive assessment of the electrical and mechanical measures obtained by pacing standard RV site (Right ventricular apex, RVA) and alternative RV site (right ventricular septum, RVS). Specifically, the two pacing sites will be compared in terms of electrical dyssynchrony, as assessed by ECG criteria, and in terms of mechanical dyssynchrony, as assessed by echocardiographic criteria.
The primary end point of the study is defined through the evaluation of dyssynchrony measured both in spontaneous rhythm (Vs) and paced rhythm (Vp). The delay between the time to peak systolic velocity of the septum and the LV free wall will be used to define the degree of dyssynchrony; this measurement will be obtained by TDI echocardiographic technique.
Patients will receive any commercially available dual-chamber implantable pacemakers, according to current standard indications. At the end of the implantation and at follow-up visits (12 and 24 months) device programming will follow the clinical practice of the center.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Catania, Italy, 95124
- Recruiting
- Azienda Ospedaliero Universitaria "Vittorio Emanuele"
-
Principal Investigator:
- Valeria Calvi, MD
-
Naples, Italy, 80142
- Recruiting
- Ospedale Santa Maria di Loreto Mare
-
Contact:
- Carmine Muto, MD
- Email: carminemuto@libero.it
-
Principal Investigator:
- Carmine Muto, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- indication for a dual chambers cardiac pacemaker device (DDD/DR) according to current guidelines
- Patients who are able to understand and sign an informed written consent
- Patients who will conduct the follow-up in the center for at least 24 months
- Patients age ≥ 18
Exclusion Criteria:
- Patients with chronic atrial fibrillation or atrial arrhythmias not controlled within 90 days before enrollment
- Pre-existing permanent cardiac pacemaker (PM), defibrillator (ICD) or cardiac resynchronization therapy device (CRT)
- Unplanned or emergency access to the hospital and / or inability to measure the dyssynchrony for the absence of spontaneous rhythm
- Patients participating in other studies that clearly impact the clinical practice of the center or whose protocol would conflict or affect the outcome of this study
- Patient not expected to survive for the duration of the study follow-up due to co-morbid medical condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Right Ventricular Apex (RVA)
In the RVA group the right ventricular pacing lead will be implanted in the apex region of the right ventricle
|
|
EXPERIMENTAL: Right Ventricular Septum (RVS)
In the RVS group the right ventricular pacing lead will be implanted in the septal region (mid septum) of the right ventricle
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
LV dyssynchrony as measured by Electromechanical delay (EMD
Time Frame: 2 weeks
|
The primary outcome measure of this study is to compare the effect of RV Septal (RVS) versus RV Apical (RVA) pacing as measured by echocardiographic/Doppler Index
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of heart failure-related hospitalization
Time Frame: 24 months
|
To compare the rate of heart failure-related hospitalization between RVS versus RVA pacing
|
24 months
|
Right ventricular lead and total implant procedure time, fluoroscopy time
Time Frame: Implant
|
To compare the procedural time of RVS versus RVA pacing
|
Implant
|
Change from baseline in R wave in 12-lead ECG
Time Frame: 24 months
|
To investigate the relationship between the ECG characteristics at baseline and response to cardiac pacing (as measured by echocardiography as defined in primary outcome measure) at implant and 24 months
|
24 months
|
Absolute change in LVEF
Time Frame: 24 months
|
To evaluate the Left ventricular diastolic and systolic function as measured by Echocardiographic response of absolute change in LVEF
|
24 months
|
LV dyssynchrony as measured by Electromechanical delay (EMD)
Time Frame: 24 months
|
The secondary outcome measure of this study is to compare the effect of RVS versus RVA pacing as measured by echocardiographic/Doppler Index.
This extends to 24 months the results obtained with the primary objective at 2 weeks
|
24 months
|
Symptoms and quality of life scores
Time Frame: 24 months
|
To investigate the relationship between the right ventricular lead position and response to cardiac pacing in terms of symptoms and quality of life scores as measured by short form (SF)-12 scores
|
24 months
|
Collaborators and Investigators
Investigators
- Study Chair: Valeria Calvi, MD, Azienda Ospedaliero Universitaria "Vittorio Emanuele" - Ferrarotto
Publications and helpful links
General Publications
- Muto C, Calvi V, Botto GL, Pecora D, Porcelli D, Costa A, Ciaramitaro G, Airo Farulla R, Rago A, Calvanese R, Baratto MT, Reggiani A, Giammaria M, Patane S, Campari M, Valsecchi S, Maglia G. Chronic Apical and Nonapical Right Ventricular Pacing in Patients with High-Grade Atrioventricular Block: Results of the Right Pace Study. Biomed Res Int. 2018 May 22;2018:1404659. doi: 10.1155/2018/1404659. eCollection 2018.
- Muto C, Calvi V, Botto GL, Pecora D, Ciaramitaro G, Valsecchi S, Malacrida M, Maglia G. Is there a right place to pace the right ventricle? Evaluation of apical and septal positions in a pacemaker population: study protocol for a prospective intervention-control trial. Contemp Clin Trials. 2014 Nov;39(2):320-6. doi: 10.1016/j.cct.2014.10.006. Epub 2014 Oct 22.
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LM-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Block
-
Medtronic Cardiac Rhythm and Heart FailureCompletedComplete Heart Block | AV Block | AV Block Complete | 3rd Degree Heart BlockUnited States, Hong Kong
-
University Hospital of FerraraRecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Left Bundle-Branch Block | Bundle-Branch Block | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Atrioventricular Block | Heart Failure, Systolic | Ventricular Arrythmia | Heart Failure,Congestive | Bradyarrhythmia | Heart Arrhythmia | Reduced... and other conditionsItaly
-
University of Sao PauloUnknownCongenital Complete Atrioventricular Heart Block | High Grade Atrioventricular Block | Postoperative Complete Heart BlockBrazil
-
Biotronik, Inc.Active, not recruitingLeft Bundle-Branch Block | Bradycardia | Cardiomyopathies | Atrioventricular BlockUnited States
-
University of MagdeburgCompletedLeft Bundle Branch Block | High Degree AV-blockGermany
-
Centre de Recherche de l'Institut Universitaire...Recruiting
-
Boston Scientific CorporationTerminatedFirst Degree AV Block
-
Schuechtermann-KlinikMedtronicUnknownHeart Failure | Left Bundle-Branch BlockGermany
-
Imperial College Healthcare NHS TrustRigshospitalet, DenmarkRecruiting
-
Duke UniversityMedtronicCompleted
Clinical Trials on Permanent Cardiac Pacemaker Implantation
-
China National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences, Fuwai Hospital; Shanghai Jiaotong University... and other collaboratorsUnknownSick Sinus Syndrome | Permanent Pacemaker Implantation | Cardioneuroablation | Ganglionated PlexusChina
-
Tartu University HospitalNorth Estonia Medical CentreUnknownBlood Pressure
-
Baylor Research InstituteCompletedAtrioventricular Block | Bundle Branch Block | Ventricular Flutter | Pacemaker Implantation | Intraventricular Conduction DelayUnited States
-
Hospital Clinic of BarcelonaInstitut d'Investigacions Biomèdiques August Pi i Sunyer; Centro de Investigación...RecruitingConduction System Pacing | Conventional Ventricular PacingSpain
-
Abbott Medical DevicesTerminated
-
Rush University Medical CenterNot yet recruitingVasovagal Syncope | AV Block-2Nd Degree-Type 1 | Sinus Pause
-
Shanghai Chest HospitalThe Second Affiliated Hospital of Shandong University of traditional Chinese... and other collaboratorsNot yet recruiting
-
University Hospital, Clermont-FerrandLivaNova; Biotronik FranceUnknown
-
Hospital Clinico Universitario de SantiagoSpanish Society of Cardiology; Hospital Universitario Lucus AugustiRecruitingSick Sinus Syndrome | Sinus Node DysfunctionSpain
-
University of CalgaryCalgary Health TrustTerminatedAtrial Fibrillation | Cardiac Pacing, ArtificialCanada